Identifying and definitional attributes
|Metadata item type:||Data Element|
|Short name:||Castrate resistance date|
|Definition:||The date on which two consecutive rising prostate-specific antigen (PSA) levels were found despite castrate levels of testosterone in a person with cancer, expressed as DDMMYYYY.|
|Data Element Concept:||Person with cancer—castrate resistance date|
Value domain attributes
|Maximum character length:||8|
Data element attributes
Collection and usage attributes
|Guide for use:|
Where two consecutive rising prostate-specific antigen levels (PSA) were found despite castrate levels of testosterone (<50ng/dL), record the date of the second test.
For a person to be recorded as castrate resistant, PSA tests need to be at least two weeks apart and both must be higher than the test prior.
This element should be recorded in conjunction with the Castrate resistance indicator item.
Source and reference attributes
|Submitting organisation:||Cancer Australia|
National Comprehensive Cancer Network 2013. NCCN Guidelines in Oncology: Prostate Cancer Version 2.2013. National Comprehensive Cancer Network, Fort Washington
Scher HI Halabi S Tannock I et al 2008. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. Journal of Clinical Oncology 26: 1148-54
|Related metadata references:|
See also Person with cancer—castrate resistance indicator, yes/no code N
|Implementation in Data Set Specifications:|